Cole Eye Institute
Cleveland, Ohio, 44195, United States
NCT Number: NCT01774123
To evaluate the ability of different spectral domain optical coherence tomography (OCT) devices, as well as different acquisition and analysis packages, to detect disease progression in patients with multiple sclerosis with and without a history of optic neuritis
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Cleveland, Ohio, 44195, United States
Optical coherence tomography imaging of the retina has been shown to be an effective non invasive method to study retinal changes associated with multiple sclerosis induced optic neuritis. The retina is a unique structure in that it is an unmyelinated part of the central nervous system (CNS). However, it is uncertain which layer of the retina provides the best correlation with MS disease. The investigators propose a prospective, case-control study to compare OCT measurements from different parts of the retina of MS patients with optic neuritis, those without optic neuritis, and healthy controls. The investigators will then correlate the OCT measurements to clinical measures of disease. This will allow future studies to use OCT technology as a primary outcome in studying MS axonal and cell body injury of the CNS, as well as evaluating strategies in treating MS.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(MS with acute optic neuritis group):
Exclusion criteria
(MS with acute optic neuritis group):
Inclusion criteria
(MS without acute optic neuritis group):
Exclusion criteria
(MS without acute optic neuritis group):
Inclusion criteria
(healthy controls):
Exclusion criteria
(healthy controls):
Time frame: 1 day
The primary outcome is to determine the thickness of the retinal layers (measured in microns) of optic neuritis-affected eye in MS patients, as compared to controls.
Time frame: 1 day
Determine the area of the iris (measured in square microns) of optic neuritis-affected eye in MS patients, as compared to controls.
The Cleveland Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04289909
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Paris, France
View Trial DetailsNCT03451955
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Copenhagen, Frederiksberg, Denmark
View Trial DetailsNCT01274702
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Berlin, Germany
View Trial DetailsNCT04792866
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Paris, Île-de-France Region, France
View Trial Details